RT @RHEUMarampa: SKIPPAIN trial: SEC showed rapid and significant improvement of spinal pain (primary endpt) and ⬇ dis
Tweet Content
SKIPPAIN trial: SEC showed rapid and significant improvement of spinal pain (primary endpt) and ⬇ disease activity in axSpA @RheumNow #ACR20 abs0899 #ACRbest https://t.co/fKSEjwd6i9
Show on Archive Page
On
Display in Search Results
On